MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib.
no abstact availabl
apoptosis, acute leukaemia, acute myeloid leukaemia
DOI identifier: 10.1111/j.1365-2141.2012.09042.x
Sorry, we are unable to provide the full text but you may find it at the following location(s):
http://hdl.handle.net/11392/16... (external link)